Introduction
In the 19 th century, important advances in physiology arose from an unusual relationship between the physician William Beaumont and his patient Alexis St. Martin. St. Martin received a shotgun wound that left him with a sizeable opening in his stomach that did not close. Beaumont availed himself of St. Martin's unique condition and conducted some of the first digestion experiments. For 10 years he continued this research combining in vivo and in vitro approaches. For example, by tying food to a string and inserting it through the hole in St. Martin's stomach and retrieving it later, Beaumont was able to retrieve the food and observe digestion in real time. He also removed gastric juice from St. Martin's stomach watched it digest food in a test tube, providing new information on the mechanical and chemical nature of digestion. Obviously, the scientific community has come a long way since then, with new methods to study physiology and nutrition using cell lines, model organisms, and endoscopic views of the human digestive system. Nutritional scientists studying microbiology, physiology, neurobiology, immunology, epidemiology, genetics, and behavior have made substantial progress in understanding the biology of food.
Nonetheless, we have yet to comprehensively answer some major nutritional questions of wide public interest. For instance, is being vegetarian beneficial to one's health, and if so, how? Is organically farmed food healthier or only more expensive? How does the introduction of new crops and cooking methods affect our health? Can nutrition reduce risk for autoimmune diseases? Is it the high carbohydrate, high fat content, or both, of western diets that leads to obesity and metabolic syndrome? (Antico et al., 2012; Nature Editors, 2014; Feinman et al., 2014; Key et al., 2006) ? Even in cases with conclusive epidemiologic data, the underlying mechanisms that link nutrition and pathology are not entirely clear: how does obesity lead to development of insulin resistance? How does a Mediterranean diet prevent cardiovascular disease (Estruch et al., 2013; Qatanani and Lazar, 2007; Ye et al., 2012) ? These unanswered questions lend themselves to nutritional myths and inconclusive recommendations that have become all too commonplace in the daily news. As a result, the public is easily confused by opposing views supported by scientific evidence (Malik and Hu, 2007; Matarese and Pories, 2014; Willett and Stampfer, 2013) .
Nutritional questions may be easy to pose, but they are difficult to answer for reasons we outline below. Here, we propose a stem-cell-centric point of view and suggest that human stem cell models of digestive processes could be a powerful experimental system to study the physiology of digestion and nutrition in the future.
Challenges in Nutritional Science
Many discoveries in physiology have been made possible by the use of model organisms, including fish, rodents, and flies. Advanced experimental tools were developed to study these organisms, and they will continue to provide invaluable data for many years to come. However, since each species evolved to respond to distinct nutritional challenges, their responses to food differ; indeed, our diet and lifestyle are strikingly different from those of model organisms. Moreover, most model organisms have limited genetic and environmental variability. On the other hand, primary and immortalized human cell lines are easy to manipulate, are amenable to imaging and screening, and provide highly reproducible results. Yet, immortalized cell lines differ metabolically from cells in vivo and are limited in their ability to teach us about the function of organs and the intra and inter-organ signaling.
Digestion is a complex process performed physically and chemically by the gastrointestinal (GI) organs and exocrine glands together with gut bacteria. Food is sensed in the gut by enteroendocrine cells that prepare the body for the incoming meal: For example, the hormone Cck regulates the release of pancreatic enzymes, Pyy signals to neurons that regulate satiety and behavior, Glp1 sensitizes insulin-secreting cells in anticipation for the increase in blood glucose (Psichas et al., 2015) . The immune system sustains a symbiotic relationship with gut bacteria necessary for digestion (Round and Mazmanian, 2009) , and the enteric and nervous systems regulate gut motility, behavior, and blood circulation through chemical and physical sensing of food. Metabolites themselves act as signaling molecules, capable of binding nuclear receptors such as the PPAR proteins. All cells consume metabolites and change their cell biology in accordance with food availability, linking nutrition to every process in the body and making nutrition a Gordian knot.
Variability between individuals must be taken into account. Not only do we have different eating habits and taste preferences, but we also vary in our ability to digest and metabolize food. Metabolic variability of individuals is largely unexplored and may be affected by numerous factors, including culture, psychology, genetics, gut microbiome composition, epigenetics, and neuroendocrine regulation.
Given these difficulties, how might one begin to systematically tackle the question of how nutrition affects health? Although we cannot literally create a window into the human gut to obtain Beaumont's view, researchers today would benefit from direct access to the human gut. Fortunately new technologies are converging in a manner that may allow us to recreate a functional GI system in vitro. Our ability to generate organoids and tissues from human embryonic stem cells (hESCs) or induced pluripotent stem cells (iPSCs) continues to make rapid progress. We may soon be able to assemble them into a miniature GI system in a dish or even on a chip. This would allow for the manipulation and analysis of digestion in a reproducible, accurate, and large-scale manner, and facilitate exploration of the effects of individual genetic and microbial diversity. Here we discuss how these pieces might come together to aid the science of nutrition.
Building a Functional Gastrointestinal System In Vitro
Intestinal organoids are miniature, three dimensional, star-shaped versions of the full intestine consisting of a single epithelial layer with crypts and villi. Stem cells at the base of the crypt can be isolated from human and mouse primary cultures, and can generate multiple cell types, such as pit cells, enteroendocrine cells, and mucus glands facing a miniature lumen. Remarkably, these organoids can be grown for long periods of time, and have been used by many labs now to study in vitro digestive enzymatic activity, development of the gut, bacterial infection, and structural aspects of the cryptvilli unit (Sato and Clevers, 2013) . Impressive progress has been recently made toward differentiating hESCs into intestinal and gastric organoids ( Other cell types can also be differentiated from hESCs. Insulin-secreting b-cells can be grown from hESCs in clusters comparable in size to an islet of Langerhans (Pagliuca et al., 2014) . Similarly, a protocol for deriving glucagon-secreting a-cells has been established (Rezania et al., 2011) . This raises the possibility of building a human stem-cell-derived islet (SC-islet) containing all the pancreatic endocrine cells types. Many labs are developing methods to differentiate hESCs into other cell types such as adipocytes (Cuaranta-Monroy et al., 2014), hepatocytes (Takebe et al., 2013) , and myocytes (Salani et al., 2012) and find appropriate culture conditions to keep cells functional for extended periods of time (Sachs and Clevers, 2014) . It is likely that we will be able to generate functional organoids and cell types such as SC-liver and SC-gut for most metabolic organs.
The ability to genetically modify stem cells that are used to make the tissues and organs will be enormously valuable in determining which genes function in which cells to affect phenotype. Advances in gene editing by TALEN and CRISPR technologies make it possible to test both loss and gain of function for specific genes and organs.
A complementary advance has come from bioengineering, making ''organson-a-chip.'' The chips are microfluidic devices, populated by cell cultures organized and perfused such that they resemble tissue and organ biology more than the classic tissue culture in a dish. The technology aims to preserve the advantages of cell culture, such as accessibility, control, and reproducibility in an environment that recapitulates in vivo physiology.
In recent years we have observed a tantalizing increase in the sophistication of organs-on-a-chip, and an emergence of a vibrant bioengineering community supporting these efforts. We are still learning how to improve upon these first generation models, and there are several challenges to overcome. Manufacturing is not entirely robust, and requires expertise of in-house engineers. More importantly, we are missing the functional equivalent of blood: a medium that will support the culture of many cell types and transport biomolecules between different organs. This bottleneck must be relieved before a modular, multi-organ system can be incorporated to study digestion and nutrition, or any other multi-organ process. Nonetheless, researchers have been able to generate increasingly complex functional models of angiogenesis, blood brain barrier, cardiovascular system, nutrient absorption, and liver drug metabolism (Bhatia and Ingber, 2014) .
In addition, maturation of the SCorgans remains a critical challenge for the success of any stem-cell-derived model. Intestinal SC-gut organoids have improved their function after transplantation under the kidney capsule of a recipient mouse (Watson et al., 2014) . It is hypothesized that vascularization is critical for this process, so proper maturation of organs may require co-culture with vascular endothelial cells, which can also be derived from stem cells (van der Meer et al., 2013) .
If these challenges can be met, it should be possible in the future to generate an in vitro system composed of several human ES-or iPS-derived cell types and organoids that will absorb food from the luminal side and be connected basally by fluid to liver, pancreas, muscle, and/ or adipose SC-derived tissue, delivering hormones and nutrients from one tissue to the next (Figure 1 ). This would circumvent problems arising from using immortal cell lines to generate organoids, as these display altered cellular metabolism and generally do not give rise to in vivo 3D structures such as a liver lobule or an islet of Langerhans. Clean human primary cultures are difficult to obtain, especially from many tissues at the same time. In vitro differentiated cells overcome these problems and can reproduce specific genetic backgrounds which can be useful for personalized medicine or simply to introduce human genetic variability into research.
Building reliable in vitro systems capable of recapitulating digestion is a monumental task requiring the collaborative efforts of labs from several fields in biology, chemistry, and engineering. Some key parts of the system are missing and integration of the stem-cell-derived tissues in a bioengineered system will be challenging. But considering the progress in the last decade in stem cell and bioengineering fields, there is good reason to believe that creating a physiological, human-based model of digestion is possible.
Incorporating Gut Microbes and Food In Vitro
An in vitro human digestive system as described above would only partially model digestive physiology. Two other important factors that need to be incorporated are food itself and the gut microbiota.
The human gut is populated by trillions of bacteria from hundreds or thousands of strains. Gut bacteria effectively form a functional organ, composed of many microbial strains that interact with the human host and perform various metabolic functions. The recognition of the importance of microbiota-host interactions is certainly not new; however, technological advancements in DNA sequencing and other methods have led to a booming increase in our knowledge on this topic . As a result, digestion is now understood to be a joint human-microbial process. The food we eat nourishes not only our organs, but also the microbial community that we host.
The challenge of maintaining a microbial ecosystem within the lumen of an in vitro system is daunting. We are just beginning to understand how to culture gut microbial strains in a dish (Goodman et al., 2011) , but initial steps toward this aim have been made. An advanced model of a gut-on-a-chip, populated by the gut anaerobic bacterium Lactobacillus rhamnosus GG and human intestinal Caco-2 cells, has been developed. Co-culturing bacteria and cells may be easier on a chip due to the constant flow of nutrients and differential culture conditions on the luminal and apical side of the intestinal epithelia (Kim et al., 2012; Kim and Ingber, 2013) . We do not yet know if in vitro systems can or should host a full complement of gut microbes, how such an ecosystem can be inoculated and sustained in culture, or what types of nutrients the bacteria will require to model digestion accurately.
In addition, the microbiota responds dynamically to diet, perhaps more so than the human gut. It changes with age and has tight interactions with its host through metabolites and the immune system. It is also highly variable between individuals and societies, representing a major source of metabolic variability (Parfrey and Knight, 2012). In vitro modeling of the gut microbiome is still at early stages, and some bacterial strains are not easily cultured in the lab. Experimenting with this system will teach us about humanmicrobiota interactions and explore how metabolic variability relates to microbiome composition.
In terms of food, the duodenum, jejunum, ileum, and colon have different digestive functions and encounter food at different digestive stages. In vitro systems should be designed such that hESC-derived intestinal segments form separate chambers (Figure 1 ) that pass food and chyme at various stages of digestion through the lumen. Tailored luminal culture conditions and chip mechanics will be required to support the introduction of food and provide appropriate conditions for gut microbiota to flourish.
Nutritional Data In Vitro and In Vivo
Nutrition science is a vast field integrating biochemical, physiological, bioinformatic, and cultural data. Mathematical modeling and big data analysis are needed, as in gut microbiota research, which includes sequencing of multi-strain samples, building statistical models of gut microbiota, and overlay of metabolic networks with microbial enzymes. Breakthroughs in microbiome research have been made possible through collaborations between microbiologists, biochemists, and computational biologists using system biology approaches (Human Microbiome Project Consortium, 2012) .
Metabolomics, the high-throughput mass spectrometry quantification of metabolites in cells, organs, and body fluids, benefits from the collaborative efforts of biochemists and computational biologists, and the data analysis tools are comparable to those of sequencing and gene expression (Melamud et al., 2010) . In the future, many more studies will likely use metabolite profiling to describe the physiology of human subjects in health and disease, leading to discovery of novel roles for metabolites and refining the known metabolic networks at the cell and organism-microbiota levels (Ryan et al., 2014) .
Similarly, nutrigenetics and nutrigenomics advance our understanding of human metabolic variability using human genetics and microbiome sequencing. A classic example is the discovery that mutations in the ldlr gene cause familial hyperlipidemia. More recent efforts to relate genetics, diet, and disease include a series of biochemical and genomewide association studies aimed at exploring connections between genetic polymorphisms, red meat, and vegetable consumption to the development of colorectal cancer (Figueiredo et al., 2014) . The Segal and Elinav labs take a different approach to understanding human metabolic variability by measuring glucose levels and food intake over the course of a week and sequencing the gut microbiome of individuals. The results are fed to a machine learning algorithm that generates a personalized diet aimed at reducing glucose spikes following meals (www.personalnutrition.org).
Many tools and approaches developed today will be instrumental for analyzing the hESC based in vitro metabolic system we envision. The various parameters influencing metabolism can be well controlled and, compared to in vivo studies, it should be possible to collect high quality, reproducible data. For example, we will be able to sample fluids containing absorbed metabolites from different positions in the in vitro gut and understand how they are affected by gut microbiota, a sudden change in diet, antibiotics, or fasting and feeding. Biopsies from the in vitro system could teach us about the proteomic and transcriptomic profile of the liver in response to feeding, with high temporal resolution. Alternatively, biopsies and fluid samples may be obtained from the system over a long period of time, without worrying about the compliance of the patient to the prescribed diet, effects associated with the immune and nervous systems of the model organism, and other uncontrolled variables.
Live imaging is much easier in vitro than in vivo. Imaging metabolic or adaptive processes is limited today to simple in vitro cultures, or to snapshots from in vivo models. Using hESC reporter lines, one will be able to track the expression of specific genes, cell composition, secretion of factors, and changes in the morphology of human tissues.
In all, the inherent complexity of nutrition and digestion may be reduced and dissected with a hESC-based in vitro system. Access to high quality imaging, metabolomics, and genomics data will allow analysis of tractable mathematical models based on large data and testing of specific biological hypotheses without the inherent difficulties of immortal cell lines.
Applications and Limitations of a Human Stem-Cell-Based System
An in vitro, complex stem-cell-based system can fill the gap between an animal in vivo model and cell lines, but cannot model the full complexity of an in vivo scenario and is not as straightforward as a cell line or primary culture. However, it can complement existing models and human studies and create an opportunity to better address physiological and nutritional questions.
The ability to use iPSCs and genome editing technology has been already put to effective use for disease modeling (Rashid et al., 2010; Wang et al., 2014) . A stem-cell-based system can be used to study nutritionally related diseases. For example, several genes have been associated with intestinal inflammatory diseases, but the role of only a handful of genes has been elucidated (Murthy et al., 2014) . It is not known whether changes in the immune system, the intestine at large, or gut microbiota triggers disease in genetically susceptible patients. More generally, the ability to genetically modify stem cells that are used to make tissues and organs will be enormously valuable in determining which genes function in which cells to affect phenotype. The advances in gene modification in this regard are all in place, making it possible to test both loss and gain of function for specific genes.
An in vitro system has applications for screens of food additives or synbiotics. Currently, studies are done on cell lines, using mice or cohorts of humans, and are not practical for the challenge. For example, how would we test which bacterial strains are most efficient at digestion of complex carbohydrates? Numerous combinations of bacterial strains should be tested in several dietary conditions and human genetic backgrounds. Such experiments would require thousands of mice, but an in vitro system might be scaled up for the task. Similarly, a controlled system is ideal for studies on the uptake of food and drugs. The differences between model organisms and humans become crucial in studying drug metabolism, and an in vitro system might better model drug metabolism, improving the efficiency of drug development.
We envision through this system will address many puzzles in the physiology of digestion. We will be able to watch bacteria break down food and pass metabolites to enterocytes, measure the level of hormones as they are secreted, and watch the intestine and microbiota adapt to a change in diet. It should be possible to model the digestive track following bariatric surgeries and study the positive and negative effects of surgery on metabolism (Mingrone and Castagneto-Gissey, 2009 ). It will also permit modeling of fecal transplants in specific genetic backgrounds and diseases.
Ultimately, our hope is that this in vitro system will go beyond the physiology of digestion into the field of nutrition. The aforementioned unanswered questions in nutrition involve the long term effects of diet, but currently organs-on-chips have been limited to shorter time scales on the order of weeks. This limitation makes such systems less valuable for the study of long term processes such as chronic disease development. However, if indeed the in vitro system can sustain cultures for longer periods of time, one could follow the metabolic profile of tissues following long term exposure to a specific diet. One could capture the development of insulin resistance in a tissue as a function of diet in a system simple enough to isolate in vivo effects exerted by the immune and nervous system, but complex enough to capture micro-environmental effects, such as liver zonation. Similarly, we could compare the long term effects of high carbohydrate versus high protein diets on two initially equivalent systems. These data will be instrumental in understanding the mechanisms underlying epidemiological and nutritional observations in human subjects (Qatanani and Lazar, 2007) .
Nutritional questions that have been raised recently, such as the advantages in organic foods or the effects of artificial sweeteners, could be addressed directly. Mice studies are illuminating, but currently, there is not sufficient human data to draw conclusions (Gardner et al., 2012; Suez et al., 2014) . By using a human-based system and data of high quality and resolution, we might be able to construct better full scale tests on human subjects, and understand the mechanisms by which sweeteners, both natural and artificial, affect our long-term risk to develop type 2 diabetes. We could feed a stem-cell-based system with organic versus non-organic food, and compare the metabolic effects on human tissues and microbiota in a controlled setting (Bara nski et al., 2014; Nature Editors, 2014) , then propose better hypotheses and design new experiments on model organisms and human subjects. Ultimately, an in vitro system could support decisions made daily by clinical nutritionists.
There are, or course, inherent limitations to such an in vitro system. It does not recapitulate all aspects of organ physiology; for example, the nervous and immune systems may prove difficult to integrate into this system. The effects of nutrition on organs such as the heart will require an addition of a heart-on-a-chip or other compatible systems (Wang et al., 2014) . An in vitro model will be smaller by 2-3 orders of magnitude than the human gut, and this physical difference limits the ability to model all physical and chemical processes. Finally, the engineering challenges in manufacturing and handling these systems may keep them from being widely applied.
Conclusions
The phrase ''an apple a day keeps the doctor away'' speaks to a link between nutrition and health. However, as a scientific community we have yet to answer comprehensively basic questions in the science of nutrition. Human nutrition is difficult to study because of its complexity, variability between individuals, and human's new foods and unique eating habits and physiology. Despite hurdles and bottlenecks, the generation of complex, stem-cell-based in vitro systems simulating physiological processes is just around the corner. We believe that the approach outlined here will allow us to begin to answer some basic, practical questions about how nutrition affects our immediate health, behavior, and the development of disease. Who is prone to gain weight and why? What is a healthy diet and how might this differ from one person to another? Nutrition scientists have good answers to some of these questions based on epidemiological data and controlled animal and human studies, but these answers lack mechanistic understanding and may not apply to specific individuals. Ultimately, we are faced with a staggeringly simple and vital question: what should we have for dinner? 
